These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25698534)

  • 1. The involvement of cell surface nucleolin in the initiation of CCR6 signaling in human hepatocellular carcinoma.
    Qiu W; Wang G; Sun X; Ye J; Wei F; Shi X; Lv G
    Med Oncol; 2015 Mar; 32(3):75. PubMed ID: 25698534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of the CCR6/CCL20 biological axis on the invasion and metastasis of hepatocellular carcinoma.
    Du D; Liu Y; Qian H; Zhang B; Tang X; Zhang T; Liu W
    Int J Mol Sci; 2014 Apr; 15(4):6441-52. PubMed ID: 24743888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway.
    Guo W; Li H; Liu H; Ma X; Yang S; Wang Z
    Oncol Rep; 2019 Sep; 42(3):1075-1089. PubMed ID: 31322256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CC chemokine receptor 6 expression predicts poor prognosis in hepatocellular carcinoma.
    Liu F; Lv H; Jia X; Liu G; Li T; Xu Z; Li J
    J Surg Oncol; 2014 Aug; 110(2):151-5. PubMed ID: 24634224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition.
    Hou KZ; Fu ZQ; Gong H
    World J Gastroenterol; 2015 Jan; 21(2):475-83. PubMed ID: 25593462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between CCL20/CCR6/Th17 axis and vascular invasion and metastasis in patients with primary hepatocellular carcinoma].
    Chang X; Wang L; Zang M; Rong W; Wu Z; Liu L; Du J; Liu J; Wu J; Qu C
    Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):5-10. PubMed ID: 25877311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis.
    Chen KJ; Lin SZ; Zhou L; Xie HY; Zhou WH; Taki-Eldin A; Zheng SS
    PLoS One; 2011; 6(9):e24671. PubMed ID: 21935436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis.
    Chen SC; Hu TH; Huang CC; Kung ML; Chu TH; Yi LN; Huang ST; Chan HH; Chuang JH; Liu LF; Wu HC; Wu DC; Chang MC; Tai MH
    Oncotarget; 2015 Jun; 6(18):16253-70. PubMed ID: 25938538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced expression and clinical significance of CC-chemokine MIP-3 alpha in hepatocellular carcinoma.
    Rubie C; Frick VO; Wagner M; Rau B; Weber C; Kruse B; Kempf K; Tilton B; König J; Schilling M
    Scand J Immunol; 2006 Jun; 63(6):468-77. PubMed ID: 16764701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HOXD3 promotes the migration and angiogenesis of hepatocellular carcinoma via modifying hepatocellular carcinoma cells exosome-delivered CCR6 and regulating chromatin conformation of CCL20.
    Wang L; Qiao C; Han L; Wang X; Miao J; Cao L; Huang C; Wang J
    Cell Death Dis; 2024 Mar; 15(3):221. PubMed ID: 38493218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCL20, a direct-acting pro-angiogenic chemokine induced by hepatitis C virus (HCV): Potential role in HCV-related liver cancer.
    Benkheil M; Van Haele M; Roskams T; Laporte M; Noppen S; Abbasi K; Delang L; Neyts J; Liekens S
    Exp Cell Res; 2018 Nov; 372(2):168-177. PubMed ID: 30287142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Downregulation of cell-surface-expressed nucleolin inhibits the growth of hepatocellular carcinoma cells in vitro].
    Meng GZ; Xiao SJ; Zeng SE; Li YQ
    Zhonghua Zhong Liu Za Zhi; 2011 Jan; 33(1):23-7. PubMed ID: 21575459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleolin identified by comparative mass‑spectra analysis is a potential marker for invasive progression of hepatocellular carcinoma.
    Qian B; Yao Y; Liu Y; Yan M; Huang Y; Chen Y
    Mol Med Rep; 2014 Sep; 10(3):1489-94. PubMed ID: 24927373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases.
    Rubie C; Frick VO; Wagner M; Weber C; Kruse B; Kempf K; König J; Rau B; Schilling M
    World J Gastroenterol; 2006 Nov; 12(41):6627-33. PubMed ID: 17075975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of chemotactic and pro-inflammatory activities of endothelial progenitor cells by hepatocellular carcinoma.
    Shih YT; Wang MC; Peng HH; Chen TF; Chen L; Chang JY; Chiu JJ
    Cell Signal; 2012 Mar; 24(3):779-93. PubMed ID: 22120522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased level of nucleolin confers to aggressive tumor progression and poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
    Guo X; Xiong L; Yu L; Li R; Wang Z; Ren B; Dong J; Li B; Wang D
    Diagn Pathol; 2014 Sep; 9():175. PubMed ID: 25230759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine/chemokine receptor pair CCL20/CCR6 in human colorectal malignancy: An overview.
    Frick VO; Rubie C; Keilholz U; Ghadjar P
    World J Gastroenterol; 2016 Jan; 22(2):833-41. PubMed ID: 26811629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma.
    Ikeda S; Kitadate A; Ito M; Abe F; Nara M; Watanabe A; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
    Oncotarget; 2016 Mar; 7(12):13563-74. PubMed ID: 26789110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CrkL meditates CCL20/CCR6-induced EMT in gastric cancer.
    Han G; Wu D; Yang Y; Li Z; Zhang J; Li C
    Cytokine; 2015 Dec; 76(2):163-169. PubMed ID: 26044596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokine receptor CCR6 as a prognostic factor after hepatic resection for hepatocellular carcinoma.
    Uchida H; Iwashita Y; Sasaki A; Shibata K; Matsumoto T; Ohta M; Kitano S
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):161-8. PubMed ID: 16706828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.